Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Healthcare Agencies II01:17

Healthcare Agencies II

There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Introduction to Language of Pathophysiology l01:25

Introduction to Language of Pathophysiology l

Pathophysiology investigates how biological mechanisms—typically starting at the cellular level—disrupt normal bodily functions. It bridges anatomy and physiology to explain the progression of disease. With this foundation, it is important to understand the following key terms used to describe disease processes: Diagnosis:The process of identifying a disease using clinical evaluation, including signs (objective evidence like rashes), symptoms (subjective experiences like pain), laboratory test...
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liquid Metal Composites Enabled High-Safety Flexible Solid-State Aluminum Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Combining VEGFR tyrosine kinase inhibitors and PD-1/PD-L1 inhibitors versus VEGFR tyrosine kinase inhibitors monotherapy in renal cell carcinoma: a target trial emulation.

medRxiv : the preprint server for health sciences·2026
Same author

scDeepAPA: a deep learning framework for single-cell alternative polyadenylation identification.

Briefings in bioinformatics·2026
Same author

Cellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology.

Cell·2026
Same author

VIRSE: a variational Bayesian framework for RNA structural ensemble inference.

Briefings in bioinformatics·2026
Same author

Reduction of next-generation sequencing files for efficient pharmacogenotype extraction.

Pharmacogenomics·2026

Related Experiment Video

Updated: Jul 12, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

PHO-Agents: A Large Language Model-Powered Multi-Agent System for Predicting Health Outcomes.

Daling Shi, Tyler Shugg, Michael T Eadon

    Medrxiv : the Preprint Server for Health Sciences
    |July 10, 2026
    PubMed
    Summary

    PHO-Agents, a novel multi-agent system, enhances health outcome prediction by integrating electronic health records with clinical evidence. This approach improves accuracy and provides interpretable results for better clinical decision support.

    More Related Videos

    Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models
    07:14

    Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models

    Published on: December 23, 2025

    Related Experiment Videos

    Last Updated: Jul 12, 2026

    Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
    03:14

    Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

    Published on: December 6, 2024

    Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models
    07:14

    Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models

    Published on: December 23, 2025

    Area of Science:

    • Artificial Intelligence in Medicine
    • Clinical Informatics
    • Health Outcome Prediction

    Background:

    • Predicting health outcomes from electronic health records (EHRs) is complex due to reliance on structured data and limited integration of external medical knowledge.
    • Traditional predictive models often lack interpretability and fail to leverage the full spectrum of available clinical information.

    Purpose of the Study:

    • To develop and evaluate PHO-Agents, a multi-agent system using large language models (LLMs) to integrate structured EHR data with text-based clinical evidence for improved health outcome prediction.
    • To enhance the interpretability and robustness of predictive models in diverse clinical settings.

    Main Methods:

    • PHO-Agents employs a multi-agent system architecture, including data, retrieval, research doctor, practical doctor, and leader agents, powered by LLMs.
    • Structured EHR sequences are encoded, and patient summaries are generated. Clinical guidelines are retrieved, and agents collaboratively analyze patient data.
    • Predictions are generated by fusing outputs from an EHR-based model and LLM agents, producing final predictions and explanation reports.

    Main Results:

    • PHO-Agents demonstrated superior performance across three real-world cohorts (AKI mortality, CKD, ICI-related adverse events) compared to single-agent and multi-agent LLM baselines.
    • Significant improvements in PR-AUC were observed, for instance, 90.20 ± 2.07 in AKI mortality prediction versus 56.46 ± 2.98 for the best baseline.
    • Ablation studies confirmed the contributions of multi-agent reasoning and logit-level fusion, with case analyses showing clinically consistent explanations.

    Conclusions:

    • PHO-Agents effectively integrates longitudinal EHR modeling with collaborative LLM reasoning, enhancing predictive performance, interpretability, and robustness.
    • This hybrid approach provides a trustworthy strategy for real-world clinical decision support, addressing limitations of traditional EHR-based models.